Skip to content

908 Devices MASS Total Equity

Total Equity at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$51.93B+5.2%
WAT
Waters CorporationWAT
$15.29B+679%
Agilent Technologies logo
Agilent TechnologiesA
$7.12B+16.1%
Bruker logo
BrukerBRKR
$2.47B+34.6%
Mettler-Toledo International, Inc. logo
Mettler-Toledo International, Inc.MTD
-$41.88M+77.0%
Danaher logo
DanaherDHR
$52.95B+4.1%

Other financials

Income statement

See full
Revenue$13.4M+13.6%
Gross profit$6.9M+24.2%
Operating income-$12.9M-16.9%
Net income-$12.0M-127%
EPS (diluted)-$0.32-126%

Balance sheet

See full
Cash & equivalents$67.6M-14.7%
Total debt$4.5M+18.6%
Total assets$186.7M-4.8%

Cash flow

See full
Operating cash flow$1.2M+108%
CapEx$40.0K-74.8%
Free cash flow$1.2M+108%

Valuation

See full
Market cap$339.57M+29.0%
Enterprise value$276.47M+47.2%
P/S5.9×+0.8×

Profitability

See full
Gross margin51.5%+1.3pp
Operating margin-76.8%-19.6pp
Net margin-62.4%+323pp
FCF margin-16.7%-7.2pp

Returns & leverage

See full
Return on equity-24.6%-149pp
Debt / equity0.0×
Current ratio3.6×-4.0×

Where this comes from

Reported directly by 908 Devices in its filing.

Tagged under the XBRL concept us-gaap:StockholdersEquity.

The official record: 908 Devices’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about 908 Devices's total equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is 908 Devices's total equity?
908 Devices (MASS) reported total equity of $134.17M in Q1 2026.
How has 908 Devices's total equity changed year-over-year?
908 Devices's total equity decreased by 15.8% year-over-year, from $159.42M to $134.17M.
What is the long-term trend for 908 Devices's total equity?
Over 5 years (2020 to 2025), 908 Devices's total equity has grown at a 0.7% compound annual growth rate (CAGR), from $139.04M to $143.7M.
What does total equity mean?
Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.